Lixisenatide Subcutaneous and Loteprednol Etabonate
Determining the interaction of Lixisenatide Subcutaneous and Loteprednol Etabonate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lixisenatide
Brand name: Adlyxin
Synonyms: Lixisenatide
Generic Name: loteprednol ophthalmic
Brand name: Alrex, Inveltys, Lotemax, Lotemax SM
Synonyms: Loteprednol (ophthalmic), Loteprednol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lixisenatide Subcutaneous-Loteprednol Eye Drops
- Lixisenatide Subcutaneous-Loteprednol Eye Drops 0.2%
- Lixisenatide Subcutaneous-Loteprednol Eye Drops 0.5% and 1%
- Lixisenatide Subcutaneous-Loteprednol Eye Gel
- Lixisenatide Subcutaneous-Loteprednol Eye Ointment
- Lixisenatide Subcutaneous-Loteprednol ophthalmic
- Loteprednol Etabonate-Lixtraxen Injection
- Loteprednol Etabonate-LMD
- Loteprednol Etabonate-LMD Injection
- Loteprednol Etabonate-LMX 4 Topical application
- Loteprednol Etabonate-LMX 5
- Loteprednol Etabonate-LMX 5 Topical application